Clinical and pharmacological aspects about the use of solvents;Aspectos clínicos e farmacológicos do uso dos solventes

Jornal Brasileiro de Psiquiatria

Volumn 49, Issue 9, 2000, Pages 331-341

  Ferigolo, Maristela ^b   Arbo, Elisangela ^b   Malysz, André Sérgio ^b   Bernardi, Rosane ^b   Barros, Helena M T ^b  

^a UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^b NONE

Author keywords

Clinical aspects of solvents abuse; Diagnosis of solvents abuse; Inhalants; Solvents

Indexed keywords

ACETONE; BENZENE; BUTANE; CHLOROFORM; ETHER; FLUOROFORM; GASOLINE; HEXANE; KEROSENE; NITROUS OXIDE; PROPANE; SOLVENT; TOLUENE; TRICHLOROETHYLENE; TRICHLOROFLUOROMETHANE; XYLENE;

BRAZIL; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL PROTOCOL; HIGH SCHOOL; HUMAN; INCIDENCE; INTOXICATION; LABORATORY TEST; LAW; LEGAL ASPECT; REVIEW; STUDENT; SUBSTANCE ABUSE;

EID: 0343807008     PISSN: 00472085     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Abbate C, Giorgianni C, Munao F, Brecciaroli R. Neurotoxicity induced by exposure to toluene. An electrophysiologic study. Int Arch Occup Environ Health 1993;64:389-92.
2. Akisu M, Mir S, Genc B, Cura A. A severe acute thinner intoxication. Turk J Pediatric 1996;38:223-5.
3. Allister C, Lush M, Oliver JS, Watson JMI. Status epilepticus caused by solvent abuse. Br Med J 1981;283:1156.
4. Alves VGF, Castro IRS, Almeida S, Catharina CV, Souza, SAAM Rosati, JLR, Torres MC, Silva, LPG. Hepatite e insuficiência renal induzidas pela inalação de substâncias cloradas ("cheirinho da loló"). Arch Bras Med 1992;66:485-8.
5. th ed. Washington, DC: American Psychiatric Association;1994.
6. Andrews LS, Snyder R. Toxic effects of solvents and vapors. In: Casarett LJ, Doull J, Klaassen CD, Amdur MO, editors. Casarett and Doull's Toxicology: the Basic Science of Poisons, 4th ed. New York: Macmillan Publishing Co.; 1991, p. 681-714.
7. Bacchiega MCM. Exame neurológico evolutivo da criança normal de 3 a 7 anos de idade. Contribuição para avaliação da fidedignidade das provas. [tese]. São Paulo(SP):Faculdade de Medicina da Universidade de São Paulo; 1979.
8. nd ed. Butterworth-Heinemann; 1996, p1389-414.
9. Bergeret J, Leblanc J. Toxicomanias. Porto Alegre(RS): Artes Médicas; 1991.
10. Bucher R. Drogas e drogadição no Brasil. Porto Alegre(RS): Artes Médicas; 1992.
11. Byrne A, Kirby B, Zibin T, Ensminger S. Psychiatric and neurological effects of chronic solvent abuse. Can J Psychiatry 1991;36:725-8.
12. Caldemeyer KS, Armstrong SW, George KK, Moran CC, Pascuzzi RM. The spectrum of neuroimaging abnormalities in solvent abuse and their clinical correlation. J Neuroimaging 1996;6:167-73.
13. Carlini EA, Cotrim BC, Monteiro MG. Abuso de solventes voláteis: aspectos epidemiológicos, médico-psicológicos e experimentais. Rev Ass Med Brasil 1988;34:61-8.
14. Comstock BS. A review of psychological measures relevant to central nervous system toxicity with specific reference to solvent inhalation. Clin Toxicol 1977;11:317-25.
15. Dinwiddie SH. Abuse of inhalants: A Review. Addiction 1994;89:925-39.
16. th ed. Cincinnati: Department of Health and Human Services; 1994.
17. Estatuto da Criança e do Adolescente. Lei Federal 8069/1990. Porto Alegre(RS): Conselho Municipal dos Direitos da Criança e do adolescente; 1997.
18. Evans EB, Balster RL. CNS depressant effects of volatile organic solvents. Neurosci Biobehav Ver 1991;15:233-41.
19. Filho DFG, Guimarães LAF. O lança-perfume e a Lei de tóxicos 6.378/76. São Paulo(SP): Faculdade de Direito de Lorena; 1976.
20. Flanagan RJ, Ives RJ. Volatile substance abuse. Bull Narc 1994;46:49-78.
21. Forster LMK, Barros HMT, Tannhauser SL, Tannhauser M. Drug use among street children in southern Brazil. Drug Alcohol Dep 1996;43:57-62.
22. Forster LMK, Barros HMT, Tannhauser SL, Tannhauser M. Meninos na rua: relação entre abuso de drogas e atividades ilícitas. ABP-APAL 1992; 14:115-20.
23. a Graus em 10 Capitais Brasileiras-1997. São Paulo(SP): Departamento de Psicobiologia da Escola Paulista de Medicina, Centro Brasileiro de Informações Sobre Drogas Psicotrópicas -CEBRID; 1997.
24. Galduróz JCF. O uso de inalantes (solventes) entre estudantes de 10 e 20 graus em dez capitais brasileiras-1993 [tese]. São Paulo: Universidade Federal de São Paulo- Escola Paulista de Medicina; 1996.
25. st ed. Oxford: Blackwell Scientific Publications. 1993. p204-22.
26. Hageman G, van der Hock J, van Hout M, van der Laan G, Steur EJ, de Bruin W, Herholz K. Parkinsonism, pyramidal signs, polyneuropathy, and cognitive decline after long-term occupational solvent exposure. J Neurol 1999; 246:198-206.
27. Hanninen H, Eskelinem L, Husman K, Nurminen M. Behavioral effects of ong-term exposure to a mixture of organic solvents. Scan J Work Environ Health 1976;2:240-55.
28. nd ed. Oxford: Butterworth-Heinemann; 1996, p.1773-92.
29. Hormes, JT. Neurologic sequelae of chronic solvent vapor abuse. Neurology 1986;35(Suppl1):698-702.
30. Indulski JA, Sinczuk-Walczak H, Szymczak, M, Wesolowski, W. Neurological and neurophysiological examinations of workers occupationally exposed to organic solvent mixtures used in paint an varnish production. Int J Occup Med Environ Health 1996;9:235-44.
31. Inhalants. Canberra: Australian Government Publishing Service; 1991.
32. Jones HE, Balster RL. Inhalant abuse in pregnancy. Obstet Gynecol Clin North Am 1998;25:153-67.
33. Jones HE, Baslter RL. Neurobehavioral consequences of intermittent prenatal exposure to high concentrations of toluene. Neurotoxicol Teratol 1997;19:305-13.
34. King MD, Day RE, Oliver JS, Lush M, Watson JM. Solvent encephalopathy. Br Med J 1981;283:663-5.
35. th ed. Rio de Janeiro: Editora Guanabara Koogan: 1991, p.1077-94.
36. Leal SMB. Alterações do eletrocardiograma de repouso em menores de rua "cheiradores de cola" não cardiopatas [dissertação]. São Paulo: Escola Paulista de Medicina- Universidade Federal de São Paulo; 1991.
37. Lindstom K. Behavioral changes after long-term exposure to organic solvents and their mixtures: determining factors and research results. Scan J Work Environ Health 1981;7(Suppl 4):48-53.
38. Malbegier, A. Neuropatia periférica por inalação voluntária crônica de benzina (n-hexano). Rev Paul Med 1990;108:142-4.
39. Morrow LA, Robin N, Hodgson MJ, Kamis H. Assessment of attention an memory efficiency in persons with solvent neurotoxicity. Neuropsychologia 1992;30:911-22.
40. Morrow LA, Steinhauer SR, Hodgson MJ. Delay in P300 latency in patients with organic solvent exposure. Arch Neurol 1992;49:315-20.
41. Noto AR, Nappo S, Galduróz JCF, Mattei R, Carlini EA. IV Levantamento sobre o Uso de Drogas entre Crianças e Adolescentes em Situação de Rua de 6 Capitais Brasileiras-1997. São Paulo: Departamento de Psicobiologia da Escola Paulista de Medicina e Centro Brasileiro de Informações Sobre Drogas Psicotrópicas - CEBRID; 1998.
42. Novak A. et. al. The deliberate inhalation of volatile substances. J Psychedelic Drug 1980;12:105-18.
43. Oerback, P. Efeitos de exposição prolongada a solventes orgânicos sobre o sistema nervoso - encefalopatia tóxica crônica e o prognóstico após o fim da exposição. Rev Bras Des Saúde Ocup 1988;2:1273-85.
44. Olson KR, editor. A Lange Clinical Manual Poisoning & Drug Overdose. California: Appleton & Lange;1990.
45. Ono A, Sekita K, Ohno k, Hirose A, et al. Reproductive and developmental toxicity studies of toluene - teratogenicity study of inhalation exposure in pregnant rats. J Toxicol Sci 1995;20:109-34.
46. Poblano A, Lope Huerta M, Martinez JM, Falcom HD. Patternvisual evoked potentials in thinner abusers. Arch Med Res 1996;27:531-3.
47. Portaria 344 de 12 de maio de 1998. Aprova o Regulamento sobre substâncias e medicamentos sujeitas a controle especial. Brasília: Diário Oficial da Repúplica Federativa do Brasil, 1999;21:29-53.
48. Prockop L, Couri D. Nervous system danage from mixed organic solvents. NIDA Res Monogr 1997;11(Suppl1):185-98.
49. Rasmussen K, Jeppesen HJ, Sabroe S. Solvent Induced chronic toxic encephalopathy. Am J Ind Med 1993;23:779-92.
50. Ron MA. Volatile substance abuse: a review of possible long-term neurological intellectual and psychiatric sequelae. Br J Psyquiatry 1986; 148:295-6.
51. Rosenberg NL et. al. Central nervous system effects of chronic toluene abuse-clinical, brainsten evoked response and magnetic resonance imaging studies. Neurotoxicol Teratol 1988; 10:489-95.
52. Seppalainen AM. Neuropsychological approaches to the detection of early neurotoxicity in humans. Crit Rev Toxicol 1988;18:245-98.
53. Smargiassi A, Mutti A, De Rosa A, De Palma G, Negrotti A, Calzetti S. A case-control study of occupational and environmental risk factors for Parkinson's disease in the Emilia-Romagna region of Italy. Neurotoxicology 1998;19:709-12.
54. Swan N. Inhalant abuse and its dangers are nothing to sniff at. Epidemiology 1993:15-19.
55. Thiesen FV (ed). Manual para monitorização biológica da exposição ocupacional a agentes químicos. Porto Alegre: EDI-PUCRS; 1996.
56. Uitti RJ, Snow BJ, Shinotoh H, Vingerhoets FJ, Hayward M, Hashimoto S, Richmond J, Markey SP, Markey CJ, Calne DB. Parkinsonism induced by solvent abuse. Ann Neurol 1994; 35(5):616-9.
57. United Nations. United Nations Convention Against Illicit Traffic In Narcotic Drugs and Psychotropic Substances. United Nations Publications; 1988.
58. Urban P, Lukas E. Vidual evoked potentials in rotogravure printers exposed to toluene. Br J Ind Med 1990:47(12):819-23.
59. Vrca A, Bozicevic D, Karacic V, Fuchs R, Prpic-Majic D, Malinar M. Visual evoked potentials in individuals exposed to long-term low concern toluene. Arch Toxicol 1995; 69(5):337-40.
60. Vrca A, Karacic V, Bozicevic D, Bozikov V, Malinar M. Brainstem auditory evoked potentials in individuals exposed to long-term low concentrations of voluene. Am J Ind Med 1996; 30(1):62-6.
61. Yamanouchi N, Okada S, Kodama K, Hirai S, et al. White matter changes caused by chronic solvent abuse. Am J Neuroradiol 1995;16(8):1643-9. 45.